» Articles » PMID: 38979457

Photolysis of Tolfenamic Acid in Aqueous and Organic Solvents: a Kinetic Study

Overview
Journal RSC Adv
Specialty Chemistry
Date 2024 Jul 9
PMID 38979457
Authors
Affiliations
Soon will be listed here.
Abstract

Tolfenamic acid (TA) is a non-steroidal anti-inflammatory drug that was studied for its photodegradation in aqueous (pH 2.0-12.0) and organic solvents (acetonitrile, methanol, ethanol, 1-propanol, 1-butanol). TA follows first-order kinetics for its photodegradation, and the apparent first-order rate constants ( ) are in the range of 0.65 (pH 12.0) to 6.94 × 10 (pH 3.0) min in aqueous solution and 3.28 (1-butanol) to 7.69 × 10 (acetonitrile) min in organic solvents. The rate-pH profile for TA photodegradation is an inverted V (∧) or V-top shape, indicating that the cationic form is more susceptible to acid hydrolysis than the anionic form of TA, which is less susceptible to alkaline hydrolysis. The fluorescence behavior of TA also exhibits a V-top-shaped curve, indicating maximum fluorescence intensity at pH 3.0. TA is highly stable at a pH range of 5.0-7.0, making it suitable for formulation development. In organic solvents, the photodegradation rate of TA increases with the solvent's dielectric constant and solvent acceptor number, indicating solute-solvent interactions. The values of decreased with increased viscosity of the solvents due to diffusion-controlled processes. The correlation between ionization potential and solvent density has also been established. A total of 17 photoproducts have been identified through LC-MS, of which nine have been reported for the first time. It has been confirmed through electron spin resonance (ESR) spectrometry that the excited singlet state of TA is converted into an excited triplet state through intersystem crossing, which results in an increased rate of photodegradation in acetonitrile.

References
1.
Hurtado M, Sankpal U, Ranjan A, Maram R, Vishwanatha J, Nagaraju G . Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer. Crit Rev Oncol Hematol. 2018; 126:201-207. PMC: 7062504. DOI: 10.1016/j.critrevonc.2018.03.016. View

2.
Sankpal U, Goodison S, Jones-Pauley M, Hurtado M, Zhang F, Basha R . Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells. Oncotarget. 2017; 8(9):14593-14603. PMC: 5362428. DOI: 10.18632/oncotarget.14651. View

3.
Ahmad I, Sheraz M, Ahmed S, Shaikh R, Vaid F, ur Rehman Khattak S . Photostability and interaction of ascorbic acid in cream formulations. AAPS PharmSciTech. 2011; 12(3):917-23. PMC: 3167265. DOI: 10.1208/s12249-011-9659-1. View

4.
Chen P, Lv W, Chen Z, Ma J, Li R, Yao K . Phototransformation of mefenamic acid induced by nitrite ions in water: mechanism, toxicity, and degradation pathways. Environ Sci Pollut Res Int. 2015; 22(16):12585-96. DOI: 10.1007/s11356-015-4537-0. View

5.
Shetty B, SCHOWEN R, Slavik M, RILEY C . Degradation of dacarbazine in aqueous solution. J Pharm Biomed Anal. 1992; 10(9):675-83. DOI: 10.1016/0731-7085(92)80096-6. View